The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

NCT00401245 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms

Interventions

DRUG: desvenlafaxine succinate sustained release
DRUG: desvenlafaxine succinate sustained release
DRUG: desvenlafaxine succinate sustained release
DRUG: desvenlafaxine succinate sustained release
DRUG: Placebo
DRUG: desvenlafaxine succinate sustained release
DRUG: desvenlafaxine succinate sustained release
DRUG: desvenlafaxine succinate sustained release

Sponsor

Pfizer